Testing effectiveness (Phase 2)Active Not RecruitingNCT07204964
What this trial is testing
Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above
Who this might be right for
Influenza, Human
GlaxoSmithKline 971